Of note, since at least 1.6 million patients take antidiabetic drugs that function as PPARβ ligands, epidemiological data on their long-term effects on tumor prevention would therefore be of value to rationally design cancer chemoprevention trials. The gene discussed is PPARD; the disease is cancer.